Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: other routes

Currently viewing:

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Acceptable study which meets basic scientific principles.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1977
Report date:
1977

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Standardised study to determine the acute toxicity of the test item in mice after single i.p. application.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Reference substance name:
Butylethanolamine
IUPAC Name:
Butylethanolamine
Details on test material:
- Name of test material (as cited in study report): Butylaethanolamin
- Analytical purity: >99%

Test animals

Species:
mouse
Strain:
NMRI
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Weight at study initiation: 22 g (mean males), 23 g (mean females)
- Diet: Altromin R 1324 Haltungsdiaet fuer Ratten und Maeuse
No further information provided.

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
other: 0.681 - 2.15% solution in aqua dest.
Details on exposure:
No data.
Doses:
68.1, 100, 147, 215 µL/kg bw (61, 89, 131, 192 mg/kg bw - conversation in mg/kg is based on the density: d= 0.8917 g/cm³).
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Frequency of weighing: before the start and at the end of the study
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 131 - < 192 mg/kg bw
Based on:
test mat.
Remarks on result:
other: Corresponds to 147/215 µL/kg; the mg/kg was calculated on the density: d= 0.8917 g/cm³. 147 µL/kg: 1 female and 3 male animals died; 215 µL/kg: all animals died
Mortality:
68.1, 100 µL/kg bw: no animals died
147 µL/kg bw: 1 male and 1 female animal died 48 hours post application; 1 female and 3 male animals died until the end of the observation period
215 µL/kg bw: all animals died
Clinical signs:
68.1 µL/kg bw: no abnormalities observed
100 µL/kg bw: irregular respiration and spastic gait
147 µL/kg bw: irregular respiration, spastic gait, apathy were observed immediately after application until the 5th day post exposure; ruffled fur and tremors on several days
Body weight:
A body weight gain was observed until the end of the observation period in the following groups:
68.1 µg/mL: 35 g (mean males), 30 g (mean females)
100 µg/mL: 33.4 g (mean males), 31.6 g (mean females)
147 µg/mL: 32.5 g (mean males), 28.2 g (mean females)
Gross pathology:
No abnormalities observed.

Applicant's summary and conclusion

Conclusions:
LD50 of >-131 - <192 mg/kg bw was established in this study.
Executive summary:

Butylethanolamine was administered intraperitoneally to 5 NMRI mice per sex and dose at dose levels of 68.1, 100, 147 and 215 µL/kg bw (61, 89, 131 and 192 mg/kg bw - conversation in mg/kg is based on the density: d= 0.8917 g/cm³) (BASF, 1977). The dilutions of the test substance were prepared in water as 0.681 - 2.15%. The animals were observed for signs of toxicity during 14 days. No animals died at 68.1, 100 µL/kg bw. At 147 µL/kg bw, 1 male and 1 female animal died 48 hours post application; 1 female and 3 male animals died until the end of the observation period. At 215 µL/kg bw: all animals died. Body weights of surviving animals decreased. No clinical signs was observed in 68.1 µL/kg bw dose group. At dose level of 100 µL/kg bw, irregular respiration and spastic gait were noted. At 147 µL/kg bw, irregular respiration, spastic gait, apathy were observed immediately after application until the 5th day post exposure; ruffled fur and tremors on several days. LD50 of >-131 -<192 mg/kg bw was established in the study.